Drosera rotundifolia
DROSERA ROTUNDIFOLIA
ORAL
HUMAN OTC DRUG
Drosera rotundifolia is an FDA drug label for the active ingredient DROSERA ROTUNDIFOLIA manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231113.
- Generic name
- DROSERA ROTUNDIFOLIA
- Manufacturer
- Boiron
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 0220-1791
- Application
- N/A
- Label effective
- 20231113
Active ingredients
Drosera 6X (**contains 0.443 mg of the active ingredient per pellet)
Indications & Usage
Spasmodic Dry Cough Worsened At Night And By Heat*
Dosage & Administration
Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Contraindications
Not available.
Warnings
Not available.
Adverse Reactions
Not available.